Literature DB >> 24469747

The presence of fragmented QRS on 12-lead ECG in patients with coronary slow flow.

Hale Yilmaz1, Baris Gungor, Tugba Kemaloglu, Nurten Sayar, Betul Erer, Mehmet Yilmaz, Nazmiye Cakmak, Ufuk Gurkan, Dilaver Oz, Osman Bolca.   

Abstract

BACKGROUND: Coronary slow flow (CSF) is characterised by delayed opacification of coronary arteries in the absence of epicardial occlusive disease. It has been reported that CSF may cause angina, myocardial ischaemia, and infarction. Fragmentation of QRS complex (fQRS) is an easily evaluated non-invasive electrocardiographic parameter. It has been associated with alternation of myocardial activation due to myocardial scar and/or ischaemia. Whether CSF is associated with fQRS is unknown. The presence of fQRS on ECG may be an indicator of myocardial damage in patients with CSF. AIM: To investigate the presence of fQRS in patients with CSF.
METHODS: Sixty patients (mean age 55.5 ± 10.5 years) with CSF and 44 patients with normal coronary arteries without associated CSF (mean age 53 ± 8.4 years) were included in this study. The fQRS was defined as the presence of an additional R wave or notching of R or S wave or the presence of fragmentation in two contiguous leads corresponding to a major coronary artery territory.
RESULTS: The presence of fQRS was higher in the CSF group than in the controls (p = 0.005). Hypertension was significantly more common in the CSF group (p < 0.001). There was no significant association between the presence of fQRS and an increasing number of vessel involvements. Logistic regression analysis demonstrated that the presence of CSF was the independent determinant of fQRS (OR = 10.848; 95% CI 2.385-49.347; p = 0.002).
CONCLUSIONS: Fragmented QRS, indicating increased risk for arrhythmias and cardiovascular mortality, was found to be significantly higher in patients with CSF. We have not found an association between the presence of fragmented QRS and the degree of CSF. Further prospective studies are needed to establish the significance as a possible new risk factor in patients with CSF.

Entities:  

Mesh:

Year:  2014        PMID: 24469747     DOI: 10.5603/KP.2013.0181

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN: 0022-9032            Impact factor:   3.108


  6 in total

Review 1.  Total Mortality, Major Adverse Cardiac Events, and Echocardiographic-Derived Cardiac Parameters with Fragmented QRS Complex.

Authors:  Bojun Gong; Zicheng Li
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-11-02       Impact factor: 1.468

2.  Are biventricular systolic functions impaired in patient with coronoray slow flow? A prospective study with three dimensional speckle tracking.

Authors:  Tuğba Kemaloğlu Öz; Mehmet Eren; Işıl Atasoy; Tayfun Gürol; Özer Soylu; Bahadır Dağdeviren
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-06       Impact factor: 2.357

3.  Prognostic Value of QRS Fragmentation in Patients with Acute Myocardial Infarction: A Meta-Analysis.

Authors:  Barış Güngör; Kazım Serhan Özcan; Mehmet Baran Karataş; İrfan Şahin; Recep Öztürk; Osman Bolca
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-28       Impact factor: 1.468

4.  The Predictive Value of Admission Fragmented QRS Complex for In-Hospital Cardiovascular Mortality of Patients with Type 1 Acute Aortic Dissection.

Authors:  Ali Kemal Kalkan; Huseyin Altug Cakmak; Mehmet Emin Kalkan; Mehmet Altug Tuncer; Ebuzer Aydin; Mehmed Yanartas; Muhammet Hulusi Satilmisoglu; Hale Unal Aksu; Mehmet Erturk; Mehmet Gul; Ugur Arslantas; Mehmet Kaan Kirali
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-23       Impact factor: 1.468

Review 5.  Fragmented QRS - Its significance.

Authors:  R N Supreeth; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2019-12-13

6.  Fragmentation of Ventricular Extrasystoles: A Potential New Electrocardiographic Window to Uncover Patients at Risk.

Authors:  Islam M Shatla; Yasser Sammour; Mahmoud El Iskandarani; Angel López-Candales
Journal:  Cureus       Date:  2021-03-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.